Back
AN2 Therapeutics Vs. GlycoMimetics Industry Stock Comparison
Sell
48
ANTX
AN2 Therapeutics
Last Price:
1.35
Seasonality Move:
-36.32%
Sell
47
GLYC
GlycoMimetics
Last Price:
0.32
Seasonality Move:
11.03%
Sell
48
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy, Sell or Hold?
- The current AN2 Therapeutics [ANTX] share price is $1.34. The Score for ANTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ANTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANTX Stock Price Chart
What is AN2 Therapeutics's stock price today?
-
The AN2 Therapeutics share price today is $1.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing slight buying pressure.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.32
The current trend is moderately bearish and GLYC is experiencing slight selling pressure.
ANTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 72.02 | Buy |
Chaikin Money Flow: | 4705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.02 - 1.18) | Buy |
Bollinger Bands (100): | (0.78 - 2.14) | Sell |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 47.47 | Sell |
Chaikin Money Flow: | -460494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.24 - 0.44) | Sell |
Bollinger Bands (100): | (0.14 - 0.32) | Buy |
ANTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.12 | Buy |
20-day SMA: | 1.1 | Buy |
50-day SMA: | 1.07 | Buy |
200-day SMA: | 2.15 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.12 | Buy |
50-day EMA: | 1.16 | Buy |
200-day EMA: | 3.51 | Sell |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.37 | Sell |
20-day SMA: | 0.39 | Sell |
50-day SMA: | 0.25 | Buy |
200-day SMA: | 0.96 | Sell |
8-day EMA: | 0.36 | Sell |
20-day EMA: | 0.35 | Sell |
50-day EMA: | 0.3 | Buy |
200-day EMA: | 0.74 | Sell |
AN2 Therapeutics Earnings Growth & ANTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
AN2 Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |